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Editorial 
Textbooks present achalasia as a relatively simple disease defined by esophageal aperistalsis and 
impaired “relaxation pressure” of the EGJ with radiographic findings that typically accompany these 
manometric findings.  The etiology of this disorder is not known but cases have been linked to an 
autoimmune process limited to the myenteric plexus of the lower esophageal sphincter (LES) and 
initiated by molecular mimicry of a viral epitope, such as HSV.1, 2  Recent recognition that certain types 
of achalasia have esophageal spasm or even preserved peristalsis (EGJ outlet obstruction) has 
broadened the definition of the disease.3, 4 At the same time the wide spectrum of histopathologic 
findings - from complete neuronal loss to lymphocytic inflammation to apparently normal 
histopathology - emphasizes that “achalasia” is a heterogeneous condition.3, 5 There are also a plethora 
of secondary causes, including genetic conditions, paraneoplastic syndromes,6 Chagas Disease7 and 
opioid induced esophageal dysmotility.8    Additionally, both benign inflammatory and malignant 
processes that involve the EGJ may produce findings similar to achalasia.   Achalasia can be viewed as 
one disease with multiple potential etiologies, with the commonality being EGJ outlet obstruction.     
The EGJ has a complex functional anatomy that includes an intrinsic physiological sphincter of smooth-
muscle within the abdominal oesophagus [LES] and gastric cardia (clasp and sling fibers) together with 
an extrinsic crural diaphragm (CD) of skeletal muscle (Figure HV panel).9 Previously the focus of 
attention in achalasia has been almost entirely on impaired LES function, although impaired relaxation 
of the proximal stomach has been documented.10, 11  
 
In this edition of Gastroenterology, researchers led by Ravi Mittal combined 3-dimensional high-
resolution manometry (3D-HRM) with detailed analysis of computed tomography images to study the 
esophago-gastric junction (EGJ) in patients with achalasia and healthy controls.(Mittal reference) This novel 
contribution describes possible abnormalities of the esophageal hiatus and CD muscle in idiopathic 
achalasia.(Mittal reference) Consistent with previous reports,12 the authors demonstrated an asymmetric, 
extrinsic CD component to EGJ pressure superimposed on the intrinsic LES. In all subjects, the LES length 
was greater on the lesser curvature as compared to the greater curvature of the stomach; whereas, LES 
related pressures were greater towards the greater curvature, at the esophago-gastric insertion angle - 
termed angle of His in anatomic studies (Figure HV panel). In achalasia patients the LES pressure 
distribution and the location of CD contraction within the EGJ high pressure zone were more variable 
and, in many cases, appeared to be abnormal. The authors attributed these changes to the asymmetric 
pull of the “noose-shaped” right crura on the abdominal esophagus.  
 
Although innovative, the measurements derived from this methodology have not been validated and 
the soft-tissue resolution of CT to differentiate EGJ structures is at the limit of what is possible even with 
Magnetic Resonance (MR) Imaging.13 Further, the mechanistic inferences are speculative and not 
necessarily consistent with published literature or clinical experience. Far from the LES being “tightly 
anchored” to the hiatus, striking shortening of the esophagus with pan-esophageal pressurization 
mediated by longitudinal muscle contraction is observed in achalasia patients and, when this occurs, the 
LES can be drawn into the chest while the diaphragmatic pinch remains in position!14, 15 Further, 
surgeons do not report that the LES is neither firmly attached to the CD nor trapped within the hiatus in 
patients referred for Heller Myotomy (personal communication, Prof. Robert Rosenberg). However, 
repeated "pulling" on the phreno-esophageal ligaments during esophageal shortening could explain the 
physical breaks (muscle tears?) in the left crus of the diaphragm observed in the paper.  
It is also clear that observational data cannot distinguish cause from effect. Choosing appropriate 
interventions to test the hypothesis is a challenge; however, Brasseur et al. have shown that it can be 
done by "pharmacological dissection".9  Mittal et al. refer to a case in which injection of botulinum toxin 
into the sphincter region inadvertently paralyzed the CD and obliterated the esophago-gastric insertion 
angle. As botulinum toxin produces profound relaxation in both smooth and striated muscle, the effects 
of injection into the LES, gastric cardia or CD could produce the same result and, therefore, cannot be 
used to differentiate biophysical effects of these structures. Studies that combined MR imaging and 
HRM to assess EGJ structure and function in gastro-esophageal reflux disease (GERD) may provide more 
insight.16, 17 The angle of His is more obtuse in GERD patients in healthy controls,17 which is interesting to 
contrast with the acute insertion angle seen in achalasia patients (Figure Achalasia and GERD panel). 
This observation could be explained by a wide hiatus or weak CD function, both common in GERD 
patients; however, anatomical studies indicate that the clasp and sling fibers at the gastric cardia also 
maintain the angle of His. The biophysical mechanism of the EGJ reflux barrier was investigated by 
repeating measurements after treatment with baclofen. This GABA-B agonist not only restored the 
insertion angle in GERD patients but also reduced transient LES relaxations and reflux events.16 Baclofen 
increases tone in the LES and the clasp and sling muscle fibers via effects on the vagal nerve;18 however, 
it relaxes the crural diaphragm... an effect that explains its utility in hiccups!19  Together, the results 
support the hypothesis that the acute insertion angle in achalasia and the obtuse insertion angle in 
GERD patients are related to variation in muscle tone within the clasp and sling fibers of the proximal 
stomach and not, or not only, with abnormal hiatal anatomy or CD function (Figure).  
 
Another issue is the part of the hypothesis that suggests that degenerative changes in the spine can 
impact on CD function is unlikely to apply in younger patients with achalasia.  Although previous work 
has demonstrated neurodegeneration secondary to obstruction in an animal model of achalasia, this 
etiology is hard to reconcile with evidence of autoimmune etiology in many patients.2, 5   
 
Achalasia may once have appeared to be a simple motility disorder; however, it is now clear that many 
etiologies result in a common presentation that responds to treatment that relieves EGJ outlet 
obstruction. It is hoped that improved understanding of the disease will lead to individual treatment 
directed at the underlying pathophysiology.  With researchers such as Mittal et al. prepared to develop 




Schematic diagram of esophago-gastric junction (EGJ) anatomy in health (central panel). Immediately 
below the lower esophageal sphincter, clasp and sling fibres fanning out from the greater to the lesser 
curvature form the distal component of the esophago-gastric junction high pressure zone. Increased 
density of these fibers on the greater than the lesser curvature could explain the variation in length and 
pressure of the sphincter between these two positions observed on 3D-HRM (lower panel). This 
anatomical arrangement may also maintain the esophago-gastic insertion angle. In achalasia patients 
with high tone in both components of the intrinsic sphincter the pressure is abnormally high and the 
insertion angle is acute (left panel). In GERD patients with low tone in the intrinsic sphincter the 
pressure is low and the angle is obtuse (right panel); however, administration of the GABA-B agonist 
baclofen increases pressure and restores the angle towards normal values. An alternative hypothesis 
proposed by Mittal et al. in this edition of Gastoenterology states that the changes in the structure and 
function of the crural diaphragm produces the effects seen on 3D-HRM and variation in the esophago-
gastic insertion angle in health and disease.  
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